Viewing Study NCT05359692


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-02-09 @ 1:28 PM
Study NCT ID: NCT05359692
Status: WITHDRAWN
Last Update Posted: 2023-09-15
First Post: 2022-04-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Sponsor: Incyte Biosciences International Sàrl
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Head and Neck Squamous Cell Carcinoma View
None Advanced Malignancies View
None Recurrent Head and Neck Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None carcinoma View
None carcinoma, squamous cell View
None squamous cell carcinoma of head and neck View
None anti-PD-(L)1 therapy View
None HNSCC View
None SCCHN View